Novo Nordisk’s Ozempic can be produced for less than $5 a month: research

Date:

A box of Ozempic and its contents lie on a table in Dudley, North Tyneside, UK, October 31, 2023.

Lee Smith | Reuters

- Advertisement -

The blockbuster diabetes drug Ozempic could be produced for less than $5 a month, even when New Nordisk fees near $1,000 per 30 days per injection within the US before insurance, a test released on Wednesday suggests.

The study by researchers from Yale University, King’s College Hospital in London and the nonprofit Doctors Without Borders raises more questions on the high price of the best-selling diabetes drug and similar weight-loss drugs which might be a part of a recent class of therapy called GLP-1.

Demand for these drugs has increased over the past 12 months whilst more insurers drop them from their plans resulting from cost, leaving some patients unable to afford the drugs.

The study also got here after years of political pressure on Novo Nordisk and other drugmakers to chop the high costs of diabetes treatment, especially insulin.

Ozempic can generally be constituted of fewer different types of insulin, in response to a study published in JAMA Network Open.

Scientists have found that the monthly supply the treatment could be produced at an estimated cost of 89 cents to $4.73. They estimated the prices of manufacturing the weekly shot together with the tax-adjusted profit margin needed to make these estimates, which they call “cost-based pricing.”

The Novo Nordisk list price for the monthly Ozempic package is $935.77 before insurance and other discounts. The findings suggest that GLP-1 “will likely be able to be produced at prices significantly lower than current levels, enabling wider access,” the researchers concluded.

In a statement Wednesday, Novo Nordisk declined to say the associated fee of manufacturing Ozempic and its weight-loss drug counterpart Wegova. However, the Danish drugmaker noted that it spent nearly $5 billion on research and development last 12 months and can spend more than $6 billion on a recent deal to extend production to fulfill demand for GLP-1.

She also stated that 75% of her gross earnings go towards rebates and rebates to make sure patients have access to her products.

The company also said Ozempic’s out-of-pocket expenses rely upon the patient’s insurance coverage. Patients with Ozempic private or industrial insurance can access a savings card and pay as little as $25 for a one-month, two-month or three-month treatment package for as much as 24 months.

Separate research by the University of Liverpool and other researchers found that Wegovy could be produced for $40 a month.

A survey released this month by Evercore ISI found that more than half of individuals currently taking GLP-1 say they pay an out-of-pocket fee of $50 or less. Nearly 75% of respondents who used certainly one of the drugs said they spent the identical amount.

Don’t miss these stories from CNBC PRO:

Rome
Romehttps://globalcmd.com/
Rome: Visionary Founder of the GlobalCommand Ecosystem (GlobalCmd.com | GLCND.com | GlobalCmd A.I.) Rome is the innovative mind behind the GlobalCommand Ecosystem, a dynamic suite of platforms designed to revolutionize productivity for entrepreneurs, freelancers, small business owners, and forward-thinking individuals. Through his visionary leadership, Rome has developed tools and content that eliminate complexity, empower decision-making, and accelerate success. The Powerhouse of Productivity: GlobalCmd.com At the heart of Rome’s vision is GlobalCmd.com, an intuitive AI-powered platform designed to simplify decision-making and streamline workflows. Whether you’re solving complex business challenges, scaling a new idea, or optimizing daily operations, GlobalCmd.com transforms inputs into actionable, results-driven solutions. Rome’s approach is straightforward yet transformative: provide users with tools that deliver clarity, save time, and empower them to focus on growth and achievement. With GlobalCmd.com, users no longer have to navigate overwhelming tools or inefficient processes—Rome has redefined productivity for real-world needs. An Ecosystem Built for Excellence Rome’s vision extends far beyond productivity tools. The GlobalCommand Ecosystem includes platforms that address every step of the user’s journey: • GLCND.com: A professional blog and content hub offering expert insights and actionable advice across business, science, health, and more. GLCND.com inspires users to explore new ideas, sharpen their skills, and stay ahead in their fields. • GlobalCmd A.I.: The innovative AI engine powering GlobalCmd.com, designed to turn user inputs into tailored recommendations, predictive insights, and actionable strategies. Built on the cutting-edge RAD² Framework, this AI simplifies even the most complex decisions with precision and ease. The Why Behind GlobalCmd.com Rome understands the pressure and challenges of running a business, launching projects, and making impactful decisions in real time. His mission was to create a platform that eliminates unnecessary complexity and provides clear, practical solutions for users. Whether users are tackling new ventures, refining operations, or handling day-to-day decisions, Rome has designed the GlobalCommand Ecosystem to meet real-world needs with innovative, results-oriented tools. Empowering Success Through Simplicity Rome’s ultimate goal is to empower individuals with the right tools, insights, and strategies to take control of their work and achieve success. By combining the strengths of GlobalCmd.com, GLCND.com, and GlobalCmd A.I., Rome has created an ecosystem that transforms how people work, think, and grow. Start your journey to smarter decisions and greater success today. Visit GlobalCmd.com and take control of your future.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Our Newsletter

Subscribe Us To Receive Our Latest News Directly In Your Inbox!

We don’t spam! Read our privacy policy for more info.

Advertisement

Popular

More like this
Related

FM NIRMALA SITHARAMAN TABLE TABLES Income tax, 2025, in Lok Sabha

On Thursday, the Minister of Finance Nirmala Sithaman presented...

Students are not doing well and our task is to save them

During my eight -year teaching profession in Colorado, I...

Powell Fed sees ways to shrink Fed Holdings

Michael S. Derby New York...